Effects of CXCL12 isoforms in a pancreatic pre-tumour cellular model: Microarray analysis

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with poor prognosis and chemoresistance.
• The tumor microenvironment, rich in extracellular components like CXCL12, influences PDAC progression.
• Six CXCL12 isoforms exist, but their specific roles in PDAC remain largely uncharacterized.

Purpose of the Study:

• To investigate the distinct roles of alpha, beta, and gamma CXCL12 isoforms in the early stages of PDAC.
• To understand how these isoforms influence gene expression and cell behavior in a pre-tumoral pancreatic model.

Main Methods:

• Utilized a human pancreatic pre-tumoral cell line (hTERT-HPNE E6/E7/KRasG12D) exposed to CXCL12 isoforms.
• Assessed gene expression changes via microarray and Real-Time PCR.
• Analyzed functional enrichment using the Enrichr tool and evaluated cell migration with wound healing assays.

Main Results:

• Microarray analysis revealed isoform-specific alterations in gene expression, with some overlap between alpha, beta, and gamma.
• The beta isoform primarily affected cell cycle regulation genes.
• All isoforms modulated genes related to cell migration, adhesion, and cytoskeleton; the gamma isoform showed the highest induction of cell migration.

Conclusions:

• CXCL12 isoforms play differential roles in PDAC onset.
• The gamma isoform's potent induction of cell migration suggests a significant role in PDAC progression.
• Further research is required to validate these preliminary findings and explore therapeutic potential.